Erste Asset Management Gmb H Erasca, Inc. Transaction History

Erste Asset Management Gmb H

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 26, 2024	SELL	$1.97 - $2.91 $49,250 - $72,750	-25,000 Closed	0 $0
Q3 2022 Nov 26, 2024	BUY	$5.82 - $10.68 $145,500 - $267,000	25,000 New	25,000 $198 Million
Q2 2022 Nov 26, 2024	BUY	$4.58 - $8.72 $114,500 - $218,000	25,000 New	25,000 $137 Million
Q1 2022 Nov 22, 2024	BUY	$8.6 - $15.48 $215,000 - $387,000	25,000 New	25,000 $225 Million

140

229M

28.7K

117K

Ticker ERAS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 122,147,000
Market Cap $330M
Description
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Erste Asset Management Gmb H with notifications on news.